2002
DOI: 10.1006/jaut.2002.0617
|View full text |Cite
|
Sign up to set email alerts
|

TNFα Inhibition in MRL/lpr Mice Ameliorates Pulmonary but not Renal Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2006
2006
2012
2012

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 55 publications
0
11
0
Order By: Relevance
“…By contrast, lung disease in MRL lpr mice involves the recruitment of CXCR3 positive T cells via local secretion of CXCL10 [37], and the endothelial expression of selectins [38] and intercellular adhesion molecule (ICAM)-1 [39]. In addition, TNF-α is a crucial mediator of lung injury in experimental lupus [40], [41]. Unspecific immunosuppressants like cyclophosphamide or dihydroorotate dehydrogenase inhibitors suppress pulmonary and renal manifestations in experimental lupus [42], [43].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…By contrast, lung disease in MRL lpr mice involves the recruitment of CXCR3 positive T cells via local secretion of CXCL10 [37], and the endothelial expression of selectins [38] and intercellular adhesion molecule (ICAM)-1 [39]. In addition, TNF-α is a crucial mediator of lung injury in experimental lupus [40], [41]. Unspecific immunosuppressants like cyclophosphamide or dihydroorotate dehydrogenase inhibitors suppress pulmonary and renal manifestations in experimental lupus [42], [43].…”
Section: Discussionmentioning
confidence: 99%
“…Unspecific immunosuppressants like cyclophosphamide or dihydroorotate dehydrogenase inhibitors suppress pulmonary and renal manifestations in experimental lupus [42], [43]. However, the aforementioned molecular and cellular pathomechanisms of autoimmune lung injury differ, at least in part, from those of lupus nephritis because Icam-1 -deficiency as well as TNF-α antagonism protects MRL lpr mice from lung but not from kidney disease [39], [41]. Furthermore, P-selectin is only induced in lungs but not in kidneys upon immune stimulation with LPS [38] or, as we found here, in experimental SLE.…”
Section: Discussionmentioning
confidence: 99%
“…Many cytokine pathways are associated with autoimmune lung disease and include IL‐1β, TNF‐α and IL‐6 (7–9). However, none of these cytokines have been reported to be active exclusively during autoimmunity.…”
Section: Introductionmentioning
confidence: 99%
“…For example, MRL/lpr mice massively overexpress TNFα. Treatment of MRL/lpr mice with a TNFα inhibitor ameliorates lung disease and skin disease [9]. Specifically in humans, TNFα is thought to contribute to the dyslipidemia of SLE and glomerular disease [10;11].…”
Section: Introductionmentioning
confidence: 99%